Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
300497.SZ Stock Price Chart
Explore Jiangxi Fushine Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300497.SZ price movements and trends.
300497.SZ Company Profile
Discover essential business fundamentals and corporate details for Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Dec 2015
Employees
1.96K
Website
https://www.fushine.cnCEO
Jian Hua Bao
Description
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.
300497.SZ Financial Timeline
Browse a chronological timeline of Jiangxi Fushine Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Apr 2025
EPS came in at ¥0.00 , while revenue for the quarter reached ¥233.70M .
Earnings released on 25 Apr 2025
EPS came in at -¥0.38 , while revenue for the quarter reached ¥200.97M .
Earnings released on 24 Oct 2024
EPS came in at -¥0.07 , while revenue for the quarter reached ¥294.46M .
Earnings released on 28 Aug 2024
EPS came in at -¥0.04 , while revenue for the quarter reached ¥341.98M .
Earnings released on 20 May 2024
EPS came in at ¥0.00 , while revenue for the quarter reached ¥340.43M .
Earnings released on 28 Apr 2024
EPS came in at -¥0.22 , while revenue for the quarter reached ¥323.23M .
Earnings released on 24 Oct 2023
EPS came in at -¥0.04 , while revenue for the quarter reached ¥430.79M .
Earnings released on 31 Aug 2023
EPS came in at -¥0.05 , while revenue for the quarter reached ¥457.73M .
Earnings released on 26 Apr 2023
EPS came in at -¥0.39 , while revenue for the quarter reached ¥415.05M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.06 , while revenue for the quarter reached ¥397.92M .
Earnings released on 26 Oct 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥401.06M .
Earnings released on 26 Aug 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥428.82M .
Earnings released on 29 Apr 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥363.56M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥402.33M .
Earnings released on 26 Oct 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥290.14M .
Earnings released on 12 Aug 2021
EPS came in at ¥0.14 , while revenue for the quarter reached ¥380.71M .
Dividend declared on 8 Jul 2021
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 8 Jul 2021.
Earnings released on 24 Apr 2021
EPS came in at ¥0.06 falling short of the estimated ¥0.81 by -92.59%, while revenue for the quarter reached ¥383.99M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.14 , while revenue for the quarter reached ¥395.13M .
Earnings released on 28 Oct 2020
EPS came in at ¥0.16 , while revenue for the quarter reached ¥292.56M .
300497.SZ Stock Performance
Access detailed 300497.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.